Machine learning can enhance disease predictions and uncover biologically meaningful associations, even with limited data.LightGBM models trained on a dataset of 10K are used to impute metabolomics features.Survival analysis is applied to assess the impact of imputed metabolomics features on disease-related risk factors.Integration of survival analysis and genetic studies with machine learning can uncover valuable biomedical insights.